Health technology transfer

British Medical Journal

Volumn 321, Issue 7264, 2000, Pages 817-820

  Harris, Eva ^a   Tanner, Marcel ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPED COUNTRY; DEVELOPING COUNTRY; HEALTH PROGRAM; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; TECHNOLOGY;

EID: 0034734857     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.321.7264.817     Document Type: Note

References (27)

1. 1 Commission on Health Research for Development. Health research: essential link to equity in development. New York: Oxford University Press, 1990.
2. 2 Global Forum for Health Research. The 10/90 report on health research 2000. Geneva: Global Forum for Health Research, 2000.
3. 3 National Intelligence Council. The global infectious disease threat and its implications for the United States. National Intelligence Estimate 2000. www.cia.gov/cia/publications/nie/report/nie99-17d.html (accessed 15 Sept 2000).
4. 4 Swiss Commission for Research Partnership with Developing Countries (KFPE). Guidelines for research in partnership with developing countries. Berne: KFPE, 1998.
5. 5 Maselli D, Sottas B. Research partnership for common concerns. Proceedings of the International Conference on Scientific Research Partnership for Sustainable Development - North-South and South-South dimensions. Hamburg: Lit Publishers, 1996.
6. 6 Harris E. A low-cost approach to PCR: appropriate transfer of biomolecular techniques. New York: Oxford University Press, 1998.
7. 7 Harris E. Developing essential scientific capability in countries with limited resources. Nat Med 1996;2:737-9.
8. 8 Harris E, Belli A, Agabian N. Appropriate transfer of molecular technology to Latin America for public health and biomedical sciences. Biochem Educ 1996;24:3-12.
9. 9 Avilés H, Belli A, Armijos R, Monroy FP, Harris E. PCR detection and identification of Leishmanía parasites in clinical specimens in Ecuador: A comparison with classical diagnostic methods classical methods. J Parasitol 1999;85:181-7.
10. 10 Balmaseda A, Sandoval E, Pérez L, Gutiérrez CM, Harris E. Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am J Trop Med Hyg 1999;61:893-7.
11. 11 Belli A, Rodriguez B, Avilés H, Harris E. Simplified PCR detection of New World Leishmania from clinical specimens. Am J Trop Med Hyg 1998;58:102-9.
12. 12 Belli A, Garcia D, Palacios X, Rodriguez B, Valle S, Tinoco E, et al. Leishmania chagasi causes widespread atypical cutaneous leishmaniasis in Nicaragua. Am J Trop Med Hyg 1999;61:380-5.
13. 13 Harris E, Sandoval E, Johnson M, Xet-Mull AM, Riley LW. Rapid subtyping of dengue viruses by restriction site-specific (RSS)-PCR. Virology 1999;253:86-95.
14. 14 Harris E, Kropp G, Belli A, Rodriguez B, Agabian N. Single-step multiplex PCR assay for characterization of New World Leishmania complexes. J Clin Microbiol 1998;36:1989-95.
15. 15 Tanner M, Kitua A, Degrémont AA. Developing health research capability in Tanzania: from the Swiss Tropical Institute Field Laboratory to the Ifakara Centre of the National Institute of Medical Research. Acta Tropica 1994;57:153-73.
16. 16 Freyvogel TA, Tanner M. Vom Feldlaboratorium des Schweizerischen Tropeninstituts zum tansanischen Ifakara Centre - Forschung in Ifakara. In: Haller-Dirr M, ed. 75 years Baldegg Sisters & Capuchin Brothers in Tanzania. Stans: Paul von Matt, 1997:138-42.
17. 17 Edoh D, Steiger S, Genton B, Beck HP. PCR amplification of DNA from malaria parasites on fixed and stained thick and thin blood films. Trans Royal Soc Trop Med Hyg 1997;91:361-3.
18. 18 Tanner M, Beck HP, Felger I, Smith T. The epidemiology of multiple Plasmodium falciparum infections. Trans R Soc Trop Med Hyg 1999;93(suppl 1):S1-68.
19. 19 Alonso PL, Smith T, Armstrong Schellenberg JRM, Masanja H, Mwankusye S, Urassa H, et al. Randomized trial of efficacy of SPf66 vaccine against P falciparum malaria in children in southern Tanzania. Lancet 1994;344:1175-81.
20. 20 Alonso Gonzalez M, Menendez C, Font F, Kahigwa E, Kimario J, Mshinda H, et al. Cost-effectiveness of iron supplementation and malaria chemoprophylaxis in the prevention of anaemia and malaria in Tanzanian infants. Bull WHO 1999;78:97-107.
21. 21 Edoh D, Mshinda H, Jenkins J, Burger M. Pyrimethamine-resistant P falciparum parasites among Tanzanian children: a facility-base study using the polymerase chain reaction. Am J Trop Med Hyg 1997;57:342-7.
22. 22 Irion A, Felger I, Smith T, Abdullah S, Mull R, Tanner M, et al. Distinction of recrudescences or new infections in a comparative trial of co-artemether (CGP 56697) and chloroquine by PCR-RFLP analysis in Tanzanian children. Trop Med Int Hlth 1998;3:490-7.
23. 23 Kitua AY, Urassa H, Wechsler M, Smith T, Vounatsou P, Weiss NA, et al. Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationship with clinical malaria and with entomological inoculation rates. Parasit Immunol 1999;21:307-17.
24. 24 Lengeler C, de Savigny D, Mshinda H, Mayomhana C, Tayari S, Hatz C, et al. Community-based questionnaires and health statistics as tools for the cost efficient identification of communities at risk of urinary schistosomiasis. Int J Epidemiol 1991;20:796-807.
25. 25 Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JH, Font F, et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for the prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997;350:844-50.
26. 26 Schellenberg D, Menendez C, Kahigwa E, Font F, Galindo C, Acosta C, et al. African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death. Am J Trop Med Hyg 1999;61:431-8.
27. 27 Ad Hoc Commitee on Heath Research Relating to Future Intervention Options. Investing in health research and development. Geneva: World Health Organization, 1996. (Document TDR/Gen/96.1.)